Introduction
Morphine is a skin gillella infection occurring in groin, cavity, anal weeks and ass skin, which is more common in skin clinics. As the basis for the health-care system, primary health-care institutions are responsible for the treatment of a large number of patients. As medical technology progresses and awareness of the stockbreeds deepens, so does the treatment in the primary health-care institutions.
II. Development of treatment in primary health-care institutions
(i) Traditional treatment
In the past, primary health-care facilities relied mainly on external anti-fashion drugs, such as aphids (cromazine, icconium, etc.) and acetamines (tbiphene, etc.). These drugs are resistant to fungi by inhibiting the synthesis of fungal cell membranes. The general course of treatment is long and the patient is usually required to spray the fungi for a period of 2 to 4 weeks in order to ensure that the fungi is completely eliminated and that the recurrence is prevented. For patients with more severe conditions or with less effective external medications, oral anti-facter drugs, such as greyicillin and Icraconol, are considered, but their application at the grass-roots level is relatively limited by indicators such as the possible side effects of oral drugs and the need to monitor liver function.
(ii) Treatment status and problems
1. Misdiagnostic treatment: Inadequate awareness among primary-level medical staff of the stocket often leads to misdiagnostic treatment. The plaster needs to be identified with diseases such as rash, contact dermatitis, and red radon. However, due to the lack of dermal expertise and experience of some primary doctors, the diagnosis is based only on the patient ‘ s partial symptoms (e.g., red spots, itchings, etc.), the lack of detailed medical history inquiries, medical examinations and necessary laboratory examinations, and the risk of misdiagnosing the utensils as other diseases, thereby delaying treatment and even aggravating the condition.
Drug abuse: Drug abuse in some primary health-care institutions. On the one hand, the blind use of anti-facter drugs by some doctors without a clear diagnosis may not only delay the treatment of a patient ‘ s real illness, but may also lead to the creation of fungi resistance; on the other hand, overuse of sugary-coin hormone-type treatment units is more common. Sugar cortex hormones, while abating symptoms such as itching in the short term, inhibit local immune responses, promote fungi growth and reproduction, exacerbate and spread the disease, and form an incorrigible stock.
3. Patients are less subjectable: they have a long treatment process for cylindrical treatment, they have difficulty in using external drugs and it is difficult for some of them to adhere to medical regulations. In particular, some patients stop their own medications after a slight reduction of symptoms, resulting in the elimination of fungi and the risk of re-emergence. In addition, there is a lack of awareness of the contagious nature of the stocket and a lack of attention to personal hygiene and protection, which can also contribute to the spread of infection among themselves and among family members.
III. Outlook for treatment in primary health care units
(i) Application of precision diagnostic techniques
With the development of molecular biology, the precision diagnostic techniques of fungi will gradually be replicated in primary health-care institutions. For example, the PCR technique allows rapid and accurate detection of fungi DNA in skin samples, identifying fungi species, facilitating early diagnosis and identification of diagnosis and reducing the occurrence of misdiagnostic treatment. In addition, skin spectroscopy, as an ingenious means of screening, is able to observe microstructures on the skin surface and subsurface, as well as characterizations such as fungi, spores, etc., and provides important clues for the diagnosis of entropy and improves the accuracy of the diagnosis of doctors at the grass-roots level.
(ii) Development and rational use of new anti-fouling drugs
In the future, more efficient, low-toxic and user-friendly new anti-facter drugs will be available. For example, new exterior anti-foulbacterial drugs have better skin permeability and drug retention, which can increase local drug concentrations, enhance antibacterial effects and shorten treatment sessions. At the same time, the safety of oral antigen drugs will be further improved, with fewer side effects and better suited to use at the grass-roots level, without indicators such as frequent monitoring of liver functions. Doctors at the grass-roots level should strengthen their learning and training in anti-fouling drugs, mastering their pharmacological effects, adaptation certificates, taboos and adverse reactions, rational choice of anti-fouling drugs, depending on the patient ‘ s condition, age and physical condition, and the development of individualized treatment programmes to improve the effectiveness of treatment and reduce the incidence of drug abuse and adverse reactions.
(iii) Integrated treatment and individualization programming
Primary health-care institutions should focus on integrated treatment in condominium treatment. In addition to the application of anti-foulbacterial drugs, care for the patient ‘ s local skin should be strengthened. If the groin is kept clean and dry, so as to avoid scratching and to prevent secondary bacterial infections. For people with a combination of basic diseases such as diabetes and obesity, efforts should be made to treat basic diseases, to control blood sugar, to reduce body weight and to improve the local skin environment, so as to improve the treatment of stockbreeds. At the same time, individualized treatment programmes are developed on the basis of individual differences, such as age, sex, occupation, lifestyle, etc. For example, for patients who are physically and sweaty, skin cleaning and drying measures should be strengthened, and the frequency of use of imported drugs should be adjusted as appropriate; for elderly patients or children, the choice of more safe and effective treatments and methods needs to take into account such factors as liver and kidney function, skin tolerance, etc.
(iv) Patient education and management
Strengthening patient education and management is an important part of improving the effectiveness of treatment at the primary level. Medical staff at the primary level should provide patients with detailed information on the causes of the disease, the means of transmission, the treatment and the care required to increase their awareness of and attention to the disease. (c) Inform patients of the importance of adhering to the rules of treatment and of avoiding self-detoxification or substance abuse. At the same time, patients are directed to personal hygiene protection, such as changing underpants and avoiding the sharing of items such as towels and towels with others, in order to prevent the spread and recurrence of disease. Through the establishment of a patient follow-up system, patients are regularly reviewed and assessed, treatment programmes are adjusted in a timely manner, patients are encouraged to develop good life habits and healthy behaviour, and patients ‘ capacity for treatment compliance and self-management is improved.
Conclusions
While some progress has been made in the past in the treatment of primary health-care units, many problems and challenges remain. With the application of precision diagnostic techniques, the development and rational use of new anti-foulbacterial drugs, the development of integrated treatment and individualization programmes and the strengthening of patient education and management, the level of treatment in primary health-care units will continue to increase. This will help to improve the prognosis, reduce the rate of relapse and improve the quality of life of the patients, as well as to promote the development of health care at the grass-roots level and provide better and more efficient health care to the general population.
